Recently, two products including the Compressor Nebulizer and the Digital Blood Pressure Monitor of Lepu Medical have successfully obtained CE certificates, and the certificate issuing authority was TUV0197. In addition, the CE II. 3 Certificate Number of the Compressor Nebulizer is HD 600949350001, and the EN ISO 13485 Certificate Number of the Digital Blood Pressure Monitor is SX 600949360001. Besides, Lepu Medical has successfully renewed the Canadian ISO 13485, and the Certificate Number is 745004781.

Digital Blood Pressure Monitor can be used as medical assistant instrument at home or in medical center for adult for measuring systolic and diastolic blood pressure and heart rate.

Compressor Nebulizer is developed in conjunction with respiratory medication for the successful treatment of asthma, chronic bronchitis, allergies and other respiratory disorders.

The success of obtaining CE Certificate for the Compressor Nebulizer and the Digital Blood Pressure Monitor and renewing the Canadian ISO 13485 indicated that the Quality Management System and products of Lepu Medical have been consistently fulfilling the requirements, laws, and regulations related with EU. Simultaneously, the success has provided guarantee in terms of tendering and bidding domestically for Lepu Medical.

About Lepu Medical

Lepu Medical has gradually formed global sales and marketing capabilities since 2009. Today, Lepu has established two branches located in the Netherlands and Turkey, and one office in India. Taking these three countries as regional hubs, Lepu has developed its overseas sales & distribution network to approximate 80 countries, obtaining local registration in more than 24 countries. More than 35 products received CE certificate and 6 products got FDA approval.

Upholding “Forever innovation, Forever care” as its spirit, Lepu Medical dedicates to serve all medical personnel and patients that aiming to build the first class international brand on both products and services.

STAY BENEFITED. STAY UPDATED. STAY WITH US !

SOURCE: Lepu Medical International Sales & Marketing Department